Xiao-Yun Liu Selected Research

Xiao-Yun Liu Research Topics

Disease

13	Neoplasms (Cancer) 12/2023 - 05/2006
2	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 08/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
2	CADASIL 01/2015 - 01/2014
1	Pressure Ulcer (Bedsore) 03/2024
1	Melanoma (Melanoma, Malignant) 12/2023
1	Stroke (Strokes) 01/2023
1	Ischemic Stroke 01/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Neuroblastoma 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Dysbiosis 10/2021
1	Residual Neoplasm 01/2021
1	Hypertension (High Blood Pressure) 11/2019
1	Adenocarcinoma 08/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2019
1	Carcinogenesis 01/2019
1	Leukemia 05/2016
1	Atherosclerosis 01/2016
1	Hypercholesterolemia 01/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2015
1	Nervous System Diseases (Neurological Disorders) 05/2014
1	Fever (Fevers) 05/2014
1	Thyroid Nodule (Nodule, Thyroid) 01/2014
1	Thyroid Diseases (Thyroid Disease) 01/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2011
1	Brain Ischemia (Cerebral Ischemia) 04/2010
1	Ischemia 04/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2010
1	Spinal Cord Injuries (Spinal Cord Injury) 08/2008

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
2	phosphoserine phosphataseIBA 01/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2022 - 08/2019
2	EnzymesIBA 01/2022 - 08/2008
2	Stem Cell FactorIBA 01/2015 - 01/2014
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2015 - 01/2014
1	phosphatidyl-N-monomethylaminoethanolIBA 12/2023
1	Cysteine Dioxygenase (Dioxygenase, Cysteine)IBA 01/2023
1	aflutinibIBA 02/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Chlorogenic AcidIBA 11/2021
1	Ethanol (Ethyl Alcohol)IBA 11/2021
1	zederoneIBA 11/2021
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 11/2021
1	curcumenolIBA 11/2021
1	curcumolIBA 11/2021
1	Circulating Tumor DNAIBA 01/2021
1	Sincalide FDA Link 03/2020
1	SolventsIBA 03/2020
1	DiarylheptanoidsIBA 03/2020
1	hydrogen sulfite (bisulfite)IBA 01/2020
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 11/2019
1	HomocysteineIBA 11/2019
1	Anaplastic Lymphoma KinaseIBA 08/2019
1	CarbohydratesIBA 08/2019
1	AntigensIBA 08/2019
1	CrizotinibIBA 08/2019
1	Tyrosine Kinase InhibitorsIBA 07/2019
1	pyrotinibIBA 07/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	NucleotidesIBA 01/2019
1	Clofarabine (Clolar)FDA Link 05/2016
1	LipidsIBA 01/2016
1	Apolipoproteins E (ApoE)IBA 01/2016
1	Therapeutic UsesIBA 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	Monoclonal AntibodiesIBA 07/2011
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2010
1	Imatinib Mesylate (Gleevec)FDA Link 03/2010
1	Glutamic Acid (Glutamate)FDA Link 08/2008
1	Neuroprotective AgentsIBA 08/2008
1	neonatal Fc receptorIBA 05/2006
1	Complement System Proteins (Complement)IBA 05/2006

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2019
2	Transplantation 10/2021 - 05/2014
2	Drug Therapy (Chemotherapy) 01/2021 - 08/2019
1	Nursing Care 03/2024
1	Treatment Delay 01/2023
1	Immunotherapy 01/2022
1	Fecal Microbiota Transplantation 10/2021
1	Hepatectomy 01/2021
1	Adjuvant Chemotherapy 01/2021
1	Chronotherapy 05/2016
1	Hematopoietic Stem Cell Transplantation 08/2015
1	Thyroidectomy 01/2014